Published in Cancer Weekly, April 6th, 2010
"Here we show that members of the RB and E2F families bind directly to the RB promoter. To investigate how the RB/E2F pathway may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.